Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Read the latest expert‐written articles on recently published manuscripts that make influential contributions to the body of infectious diseases literature.

In the Literature

Pharmacomicrobiomic Study Shows Significant Gut Bacteria Role in Drug Metabolism and Exposure
A recent study provides what may be the first in-depth examination of the molecular mechanism of biotransformation of a large number of orally administered agents by the human gut microbiota.
Comparing Effectiveness of Agents for MSSA Bacteremia
Evidence demonstrates that antimicrobial therapy with an anti-staphylococcal β-lactam antibiotic is the gold standard for treatment of SAB caused by MSSA, but confusion about which agent—particularly cefazolin versus an anti-staphylococcal penicillin—is preferred remains an unanswered question
Does Decreased Renal Function Predict Worse Outcomes With Newer Antimicrobials?
Numerous studies need to be performed to ensure adequate antimicrobial dosing, partic­ularly in the setting of renal impairment and critical illness.
Postulates About the Prostate: Fosfomycin for Chronic Bacterial Prostatitis
Fosfomycin is an attractive potential option because it does not cross-react with other antimicrobials, making it a good choice in patients with extensive drug allergies.
 
Utilizing MRSA Nasal Screening for Antimicrobial Stewardship
This In the Literature piece details a study evaluating MRSA nasal screening’s effect on antimicrobial stewardship.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?